Select Bibliography

Filter by any of these (after searching):

Wigle, Dennis

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 7 items

Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503)

Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - AATS - - 2018

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-140503

Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503)

Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - - Lancet Respir Med - 2018

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0010

Survival implications of variation in the thoroughness of pathologic lymph node examination in American College of Surgeons Oncology Group Z0030 (Alliance)

Osarogiagbon, Raymond U. , Decker, Paul A. , Ballman, Karla ... - - Ann. Thorac. Surg. - 2016

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030

Survival implications of variation in the lymph node (LN) count in ACOSOG Z0030 (Alliance)

Osarogiagbon, Raymond U. , Decker, Paul , Ballman, Karla ... - IASLC (WCLC) - J Thorac Oncol - 2015

Abstract - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030

Adjuvant targeted therapy following standard adjuvant therapy for resected NSCLC: An initial report from ALCHEMIST (Alliance A151216)

Oxnard, Geoffrey R. , Mandrekar, Sumithra , Hillman, Shauna ... - IASLC (WCLC) - J Thorac Oncol - 2018

Abstract - No-Endpoint - Preliminary - Respiratory - A151216

ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high risk resected NSCLC (Alliance)

Sands, Jacob , Oxnard, Geoffrey R. , Kozono, David ... - ASCO - J Clin Oncol - 2020

Abstract - No-Endpoint - Trial-Description-Only - Respiratory - A081105 , A151216 , A081801

Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]).

Yoon, Harry H , Ou, Fang-Shu , Soori, Gamini S , Shi, Qian ... - - Eur J Cancer - 2021

Manuscript - Primary - Primary - GI - N0849